stethoscopes

...

Tony LoSasso and Kosali Simon

By Tony LoSasso and Kosali Simon

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


The reemergence of the debate over the now-expired Affordable Care Act (ACA) enhanced premium tax credits has thrust the issue to the forefront. And along with it, the deeply misleading framing that millions of Americans have lost or are losing coverage because of the loss of government subsidies. A reality check is in order.

What happened at the end of 2025 is that the temporary, pandemic-era expansion of premium subsidies and the removal of the income cap expired, years after the pandemic ended. The net result is a reduction in the share of premiums paid by the federal government from 88 percent to 83 percent. The government is still bearing the lion’s share of health insurance premiums for these families.

However, not all ACA-subsidized enrollees are being impacted the same way. Medicaid eligibility remains unchanged, and lower-income exchange enrollees are continuing to receive substantial subsidies under the original ACA rules. In other words, the families facing the greatest economic hardship remain largely insulated from this change. Rather, the most significant effects fall on middle- and upper-middle-income households who became newly eligible for generous subsidies during the pandemic. While some affected enrollees are undoubtedly reassessing their coverage choices, the change does not automatically translate into widespread coverage losses, nor does it dismantle the ACA’s pre-pandemic coverage architecture.

Read More on Opinion

None of this is to deny that rising premiums impose real financial strain. But the prevailing political response—extending and expanding subsidies—confuses relief with reform. Premium subsidies are a Band-Aid: they reduce what households pay out of pocket without doing anything to slow the underlying growth of health care costs. Using subsidies to mask premium increases drains scarce political energy away from the deeper work of cost reform, reshaping not only who pays the bill but also delaying pressure to reduce the bill itself.

stethoscopes

...

When enrollees pay a shrinking share of premiums, insurers and providers face weaker pressure to compete aggressively on price. Premium increases become someone else’s problem—namely, the taxpayer’s. Over time, this insulation predictably feeds into higher prices, not lower ones. Subsidies that grow automatically with premiums may protect consumers in the short run, but they also blunt the very market forces that could restrain costs in the long run.

This dynamic exposes a deeper limitation of the Affordable Care Act. The ACA succeeded in expanding and improving the quality of coverage, particularly for lower-income Americans. But serious cost-containment mechanisms have proved elusive. Its architecture relied heavily on regulated competition and masking the true cost of health insurance through generous premium subsidies, creating the appearance of affordability. There was a further assumption that insurers and providers would discipline prices in response to consumer choice. That discipline has proven weak, especially in markets dominated by consolidated hospital systems and limited insurer competition.

The policy response to this failure has been to layer ever-larger subsidies on top of a system that continues to produce rapidly rising premiums. This approach treats symptoms while ignoring causes. It allows policymakers to claim they are protecting coverage without confronting the structural forces driving costs upward.

If affordability is the goal, real reform must focus on those forces. That means addressing provider market power, ensuring competition in hospital and physician markets, and reforming payment systems that reward pricing leverage rather than value. It also means restoring genuine market discipline in the health insurance exchanges themselves. Too often, exchange competition has centered on benefit design and network narrowness rather than price, because marginal premium differences matter little to consumers whose subsidies rise automatically with benchmark premiums.

None of these reforms are easy. All of them involve political conflict. And that reality helps explain why subsidy expansions are so attractive. They are fast, visible, and win votes. They allow elected officials to avoid challenging powerful interests that benefit from high prices while presenting themselves as defenders of affordability. They avoid forcing explicit choices between higher taxes, lower provider prices, or more limited coverage—choices that real cost control inevitably entails.

But this strategy comes with a cost. Each “temporary” extension raises expectations, normalizes affordability that exists only because of subsidies, and increases the political difficulty of ever returning to a system in which insurers and providers compete on price. Over time, subsidies cease to be a bridge and become a substitute for reform.

Treating the expiration of pandemic-era subsidies as a crisis has made for compelling headlines and sound bites, but it obscures the harder truth: affordability cannot be purchased indefinitely with taxpayer dollars. Paying 90 percent of the bill for the median household is not sustainable health reform if we also care about funding other public priorities. If policymakers are serious about building a sustainable health insurance system, they must confront the drivers of rising premiums rather than continually expanding the subsidies designed to hide them.

Tony LoSasso is the Robert F. and Sylvia T. Wagner Professor of Public Affairs at the University of Wisconsin. Kosali Simon is Distinguished Professor of Economics at Indiana University.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines